A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation

ConclusionA new prognostic model was developed and validated to estimate overall survival of patients with previously treated mRCC. This model is an easy-to-use tool that allows accurate estimation of patient survival to inform decision making and follow-up after first line for mRCC.
Source: Angiogenesis - Category: Molecular Biology Source Type: research